Analyst firms · Morgan Stanley · IRON
Morgan Stanley IRON price target and rating history
Disc Medicine Inc. (IRON) · Health Care
Morgan Stanley rates Disc Medicine Inc. (IRON) Overweight with a $85 price target, as of its latest action on Jul 3, 2025. It has published 4 rating actions on IRON since April 2023, including 1 upgrade and 1 downgrade.
- Current rating
- Overweight
- Price target
- $85
- Median target, all firms
- Too few
- Actions on IRON
- 4
Morgan Stanley price target on IRON
Every Morgan Stanley rating on IRON
- Jul 3, 2025
- Nov 5, 2024
- Dec 19, 2023
- Apr 20, 2023
Questions about Morgan Stanley and IRON
- What is Morgan Stanley's price target for IRON?
- Morgan Stanley's latest stated price target for Disc Medicine Inc. (IRON) is $85, from its action on Jul 3, 2025.
- What is Morgan Stanley's rating on IRON?
- Morgan Stanley rates IRON Overweight, a bullish rating, as of Jul 3, 2025.
- When did Morgan Stanley last change its view on IRON?
- On Jul 3, 2025, Morgan Stanley resumes coverage at Overweight, price target $85.
More IRON rating histories
All Morgan Stanley ratingsIRON news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.